204 related articles for article (PubMed ID: 21422528)
1. Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AβPP transgenic mice.
Yu J; Gattoni-Celli M; Zhu H; Bhat NR; Sambamurti K; Gattoni-Celli S; Kindy MS
J Alzheimers Dis; 2011; 25(2):295-307. PubMed ID: 21422528
[TBL] [Abstract][Full Text] [Related]
2. Treatment with D3 removes amyloid deposits, reduces inflammation, and improves cognition in aged AβPP/PS1 double transgenic mice.
van Groen T; Kadish I; Funke SA; Bartnik D; Willbold D
J Alzheimers Dis; 2013; 34(3):609-20. PubMed ID: 23271316
[TBL] [Abstract][Full Text] [Related]
3. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
[TBL] [Abstract][Full Text] [Related]
4. Effects of GrandFusion Diet on Cognitive Impairment in Transgenic Mouse Model of Alzheimer's Disease.
Yu J; Zhu H; Taheri S; Mondy W; Perry S; Kirstein C; Kindy MS
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33396967
[TBL] [Abstract][Full Text] [Related]
5. Delayed amyloid plaque deposition and behavioral deficits in outcrossed AβPP/PS1 mice.
Couch BA; Kerrisk ME; Kaufman AC; Nygaard HB; Strittmatter SM; Koleske AJ
J Comp Neurol; 2013 Apr; 521(6):1395-408. PubMed ID: 23047754
[TBL] [Abstract][Full Text] [Related]
6. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
[TBL] [Abstract][Full Text] [Related]
7. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence.
Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR
J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825
[TBL] [Abstract][Full Text] [Related]
8. Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice.
Yan P; Bero AW; Cirrito JR; Xiao Q; Hu X; Wang Y; Gonzales E; Holtzman DM; Lee JM
J Neurosci; 2009 Aug; 29(34):10706-14. PubMed ID: 19710322
[TBL] [Abstract][Full Text] [Related]
9. A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's disease.
Havas D; Hutter-Paier B; Ubhi K; Rockenstein E; Crailsheim K; Masliah E; Windisch M
J Alzheimers Dis; 2011; 25(2):231-43. PubMed ID: 21403389
[TBL] [Abstract][Full Text] [Related]
10. Cerebellar amyloid-β plaques: disturbed cortical circuitry in AβPP/PS1 transgenic mice as a model of familial Alzheimer's disease.
Lomoio S; López-González I; Aso E; Carmona M; Torrejón-Escribano B; Scherini E; Ferrer I
J Alzheimers Dis; 2012; 31(2):285-300. PubMed ID: 22561329
[TBL] [Abstract][Full Text] [Related]
11. Serum β-amyloid peptide levels spike in the early stage of Alzheimer-like plaque pathology in an APP/PS1 double transgenic mouse model.
He J; Qiao JP; Zhu S; Xue M; Chen W; Wang X; Tempier A; Huang Q; Kong J; Li XM
Curr Alzheimer Res; 2013 Nov; 10(9):979-86. PubMed ID: 24117120
[TBL] [Abstract][Full Text] [Related]
12. Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer's Disease-Like Pathologies in AβPP(swe)/PS1(ΔE9) Mice.
Qiu H; Zhong R; Liu H; Zhang F; Li S; Le W
J Alzheimers Dis; 2016; 50(3):669-85. PubMed ID: 26757041
[TBL] [Abstract][Full Text] [Related]
13. Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's disease.
Murakami K; Murata N; Ozawa Y; Kinoshita N; Irie K; Shirasawa T; Shimizu T
J Alzheimers Dis; 2011; 26(1):7-18. PubMed ID: 21558647
[TBL] [Abstract][Full Text] [Related]
14. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
[TBL] [Abstract][Full Text] [Related]
15. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
[TBL] [Abstract][Full Text] [Related]
16. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
17. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model.
Faivre E; Hölscher C
J Alzheimers Dis; 2013; 35(2):267-83. PubMed ID: 23568101
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
19. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
[TBL] [Abstract][Full Text] [Related]
20. O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment.
Kim C; Nam DW; Park SY; Song H; Hong HS; Boo JH; Jung ES; Kim Y; Baek JY; Kim KS; Cho JW; Mook-Jung I
Neurobiol Aging; 2013 Jan; 34(1):275-85. PubMed ID: 22503002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]